Allegra coated tablets 120 mg, # 10

Allegra tab.

p / o captivity.

120 mg No. 10

Name ENG

ALLEGRA

Clinical and pharmacological group

Blocker of histamine H1 receptors.

Antiallergic drug

ATX code

Fexofenadine

Dosage

120mg

Structure

Light pink film-coated tablets, oblong, biconvex, engraved with 012" on one side and stylized "e" on the other.

.Auxiliary substances: croscarmellose sodium - 24 mg, pregelatinized starch - 120 mg, microcrystalline cellulose - 133 mg, magnesium stearate - 3 mg.

The composition of the shell: hypromellose E-15 - 2.84 mg, hypromellose E-5 - 1.89 mg, povidone - 510 Ојg, titanium dioxide (E171) - 2.025 mg, colloidal silicon dioxide - 730 Ојg, macrogol 400 - 3.94 mg, pink mixture of dye iron oxide (iron oxide red (E172), titanium dioxide (E171)) - 250 Ојg, yellow mixture of iron dye (iron oxide yellow (E172), titanium dioxide (E171)) - 40 Ојg.

Indications

Seasonal allergic rhinitis (for symptom relief) - 120 mg tablet

chronic idiopathic urticaria (to reduce symptoms) - tablets, 180 mg.

Contraindications

Hypersensitivity to any component of the drug

pregnancy

lactation period

children's age (up to 12 years old).

With care: in patients with chronic renal and hepatic insufficiency, as well as in elderly patients (lack of clinical experience in this category of patients)

in patients with cardiovascular diseases, including a history (antihistamines can cause palpitations and tachycardia).

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

INN / Active ingredient

Fexofenadine

Specifications

Category

Allergy

Scope of the drug

Leather

,

Dermatology

,

Ear, Throat, Nose

Release form

Tablet

Manufacturer country

France

Package quantity, pcs

ten

Scope of application

Allergology

,

Dermatology

Minimum age from

12 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Sanofi

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

R06AX26 Fexofenadine

Dosage form

Film-coated tablets

The target audience

Children

Expiration date in days

1095

Dosage (volume) of the substance in the preparation

fexofenadine hydrochloride 120 mg

Package weight, g

35

Mode of application

:

The tablets are intended for oral administration.

< br> The recommended dose of fexofenadine for chronic urticaria for adults and children 12 years and older is 180 mg once a day before meals.

< br> Patients at risk

< br> Studies in special risk groups (elderly patients, patients with renal and hepatic insufficiency) have shown that they do not need to adjust the dosage regimen.

Pharmaco-therapeutic group

:

Antiallergic agent - H1-histamine receptor blocker

"